NASDAQ:STAA - STAAR Surgical Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$26.60 +0.25 (+0.95 %)
(As of 05/21/2018 04:00 PM ET)
Previous Close$26.35
Today's Range$26.15 - $27.10
52-Week Range$8.95 - $27.10
Volume426,900 shs
Average Volume215,321 shs
Market Capitalization$1.10 billion
P/E Ratio2,660.00
Dividend YieldN/A
Beta1.21

About STAAR Surgical (NASDAQ:STAA)

STAAR Surgical logoSTAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and delivery systems to deliver the lenses into the eye. The company provides Visian implantable collamer lenses (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers minimally invasive intraocular lenses (IOLs), including foldable IOLs for use in minimally invasive cataract surgical procedures; aspheric IOLs that produce a clearer image than traditional spherical lenses; and nanoFLEX IOL, a single piece collamer aspheric optic, as well as preloaded injectors for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. It markets its products to health care providers, including ophthalmic surgeons, vision centers, surgical centers, hospitals, government facilities, and distributors primarily under the STAAR, EVO Visian ICL, Evolution in Visual Freedom, Visian, Collamer, CentraFLOW, AquaPORT, nanoFLEX, nanoPOINT, and Afinity trademarks. The company sells products directly through its sales representatives in the United States, Japan, Spain, Germany, Canada, the United Kingdom, and Singapore, as well as through independent distributors in approximately 75 countries. STAAR Surgical Company was founded in 1982 and is headquartered in Monrovia, California.

Receive STAA News and Ratings via Email

Sign-up to receive the latest news and ratings for STAA and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Ophthalmic goods
Sub-IndustryHealth Care Supplies
SectorMedical
SymbolNASDAQ:STAA
CUSIP85231230
Phone626-303-7902

Debt

Debt-to-Equity Ratio0.03
Current Ratio2.43
Quick Ratio1.90

Price-To-Earnings

Trailing P/E Ratio2,660.00
Forward P/E Ratio886.67
P/E GrowthN/A

Sales & Book Value

Annual Sales$90.61 million
Price / Sales12.22
Cash Flow$0.0923 per share
Price / Cash288.25
Book Value$1.04 per share
Price / Book25.58

Profitability

EPS (Most Recent Fiscal Year)$0.01
Net Income$-2,130,000.00
Net Margins0.66%
Return on Equity6.80%
Return on Assets4.04%

Miscellaneous

Employees353
Outstanding Shares41,620,000

STAAR Surgical (NASDAQ:STAA) Frequently Asked Questions

What is STAAR Surgical's stock symbol?

STAAR Surgical trades on the NASDAQ under the ticker symbol "STAA."

How were STAAR Surgical's earnings last quarter?

STAAR Surgical (NASDAQ:STAA) released its earnings results on Wednesday, May, 2nd. The medical instruments supplier reported $0.04 earnings per share for the quarter, beating the consensus estimate of ($0.04) by $0.08. The medical instruments supplier had revenue of $27.09 million for the quarter, compared to the consensus estimate of $23 million. STAAR Surgical had a return on equity of 6.80% and a net margin of 0.66%. During the same quarter last year, the business posted ($0.05) earnings per share. View STAAR Surgical's Earnings History.

When is STAAR Surgical's next earnings date?

STAAR Surgical is scheduled to release their next quarterly earnings announcement on Wednesday, August, 1st 2018. View Earnings Estimates for STAAR Surgical.

What price target have analysts set for STAA?

4 analysts have issued 1-year target prices for STAAR Surgical's shares. Their predictions range from $21.00 to $23.00. On average, they expect STAAR Surgical's stock price to reach $21.6667 in the next twelve months. View Analyst Ratings for STAAR Surgical.

What are Wall Street analysts saying about STAAR Surgical stock?

Here are some recent quotes from research analysts about STAAR Surgical stock:
  • 1. Canaccord Genuity analysts commented, "We hosted CEO Caren Mason for a day of investor meetings in the Mid- Atlantic last week, coming away from discussions with increased conviction in the merits of the STAA turnaround story. We think management has “primed the pump” (product pipeline) extraordinary well, and expect STAA to deliver revenue growth acceleration through 2020 at least. Timing of FDA re-inspection and Warning Letter “lift” is in the agency’s court, but we continue to get the sense that the firm has dedicated significant resources to satisfy FDA inspectors once they commence their unannounced visit. The US market clearly represents an enormous potential growth engine for STAA, so removal of the Warning Letter could be a bullish catalyst for the stock, in our view." (4/24/2018)
  • 2. According to Zacks Investment Research, "Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma. " (4/12/2018)

Who are some of STAAR Surgical's key competitors?

Who are STAAR Surgical's key executives?

STAAR Surgical's management team includes the folowing people:
  • Ms. Caren L. Mason, Chief Exec. Officer, Pres and Director (Age 64)
  • Dr. Keith Holliday, Chief Technology Officer (Age 55)
  • Mr. Samuel J. Gesten J.D., Chief Legal Officer & Corp. Sec. (Age 56)
  • Mr. Hans-Martin Blickensdoerfer, Sr. VP of Commercial Operations - Europe & China (Age 53)
  • Ms. Deborah Andrews, Chief Financial Officer (Age 61)

Has STAAR Surgical been receiving favorable news coverage?

Media headlines about STAA stock have been trending somewhat positive this week, Accern reports. The research firm identifies negative and positive press coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. STAAR Surgical earned a news impact score of 0.17 on Accern's scale. They also gave press coverage about the medical instruments supplier an impact score of 48.04 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the next several days.

Who are STAAR Surgical's major shareholders?

STAAR Surgical's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Palo Alto Investors LP (8.45%), BlackRock Inc. (6.53%), Baillie Gifford & Co. (2.58%), Cortina Asset Management LLC (0.95%), Millennium Management LLC (0.79%) and Principal Financial Group Inc. (0.50%). Company insiders that own STAAR Surgical stock include Broadwood Partners Lp, Caren L Mason, Deborah J Andrews, Hans-Martin Blickensdoerfer, Keith Holliday and Samuel J Gesten. View Institutional Ownership Trends for STAAR Surgical.

Which major investors are selling STAAR Surgical stock?

STAA stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC, Cortina Asset Management LLC, Lincoln National Corp, A.R.T. Advisors LLC, Principal Financial Group Inc., Principal Financial Group Inc., Barclays PLC and Public Employees Retirement Association of Colorado. Company insiders that have sold STAAR Surgical company stock in the last year include Caren L Mason, Deborah J Andrews, Keith Holliday and Samuel J Gesten. View Insider Buying and Selling for STAAR Surgical.

Which major investors are buying STAAR Surgical stock?

STAA stock was bought by a variety of institutional investors in the last quarter, including Baillie Gifford & Co., King Luther Capital Management Corp, Next Century Growth Investors LLC, BlackRock Inc., Millrace Asset Group Inc., Palo Alto Investors LP, Element Capital Management LLC and GSA Capital Partners LLP. View Insider Buying and Selling for STAAR Surgical.

How do I buy shares of STAAR Surgical?

Shares of STAA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is STAAR Surgical's stock price today?

One share of STAA stock can currently be purchased for approximately $26.60.

How big of a company is STAAR Surgical?

STAAR Surgical has a market capitalization of $1.10 billion and generates $90.61 million in revenue each year. The medical instruments supplier earns $-2,130,000.00 in net income (profit) each year or $0.01 on an earnings per share basis. STAAR Surgical employs 353 workers across the globe.

How can I contact STAAR Surgical?

STAAR Surgical's mailing address is 1911 WALKER AVENUE, MONROVIA CA, 91016. The medical instruments supplier can be reached via phone at 626-303-7902 or via email at d[email protected]


MarketBeat Community Rating for STAAR Surgical (STAA)

Community Ranking:  1.9 out of 5 (star)
Outperform Votes:  129 (Vote Outperform)
Underperform Votes:  218 (Vote Underperform)
Total Votes:  347
MarketBeat's community ratings are surveys of what our community members think about STAAR Surgical and other stocks. Vote "Outperform" if you believe STAA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe STAA will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

STAAR Surgical (NASDAQ:STAA) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
4 Wall Street analysts have issued ratings and price targets for STAAR Surgical in the last 12 months. Their average twelve-month price target is $21.6667, suggesting that the stock has a possible downside of 18.55%. The high price target for STAA is $23.00 and the low price target for STAA is $21.00. There are currently 4 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $21.6667$20.50$20.50$20.50
Price Target Upside: 18.55% downside25.77% upside25.77% upside25.77% upside

STAAR Surgical (NASDAQ:STAA) Consensus Price Target History

Price Target History for STAAR Surgical (NASDAQ:STAA)

STAAR Surgical (NASDAQ:STAA) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/3/2018Canaccord GenuityBoost Price TargetBuy ➝ Buy$21.00 ➝ $23.00HighView Rating Details
5/3/2018StephensUpgradeEqual Weight ➝ Overweight$13.00 ➝ $21.00HighView Rating Details
4/30/2018William BlairUpgradeMarket Perform ➝ OutperformMediumView Rating Details
11/20/2017BenchmarkReiterated RatingBuy ➝ Buy$21.00N/AView Rating Details
(Data available from 5/21/2016 forward)

Earnings

STAAR Surgical (NASDAQ:STAA) Earnings History and Estimates Chart

Earnings by Quarter for STAAR Surgical (NASDAQ:STAA)

STAAR Surgical (NASDAQ:STAA) Earnings Estimates

Current Year EPS Consensus Estimate: $0.03 EPS
Next Year EPS Consensus Estimate: $0.17 EPS

STAAR Surgical (NASDAQ STAA) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/31/2018($0.02)N/AView Earnings Details
5/2/2018Q1 2018($0.04)$0.04$23.00 million$27.09 millionViewListenView Earnings Details
2/28/2018Q4 2017$0.03$0.02$24.85 millionViewListenView Earnings Details
11/8/2017Q3 2017$0.02$0.02$23.47 millionViewN/AView Earnings Details
8/2/2017Q2 2017($0.0470)($0.01)$22.15 million$21.90 millionViewListenView Earnings Details
5/3/2017Q1 2017($0.0530)($0.05)$20.35 millionViewListenView Earnings Details
3/2/2017Q4 2016($0.02)$0.02$22.25 million$22.10 millionViewListenView Earnings Details
11/3/2016Q316($0.04)($0.02)$20.70 million$20.05 millionViewListenView Earnings Details
8/3/2016Q216($0.05)($0.05)$19.88 million$21.00 millionViewListenView Earnings Details
5/11/2016Q116($0.17)($0.01)$19.60 million$19.30 millionViewListenView Earnings Details
3/2/2016Q415($0.02)$0.01$19.11 million$20.90 millionViewListenView Earnings Details
10/28/2015Q315($0.04)($0.04)$17.87 million$18.80 millionViewListenView Earnings Details
7/29/2015Q2 2015($0.02)$18.20 million$18.66 millionViewN/AView Earnings Details
4/29/2015Q115($0.04)$0.03$17.85 million$18.90 millionViewListenView Earnings Details
2/25/2015Q414($0.05)($0.03)$16.60 million$16.60 millionViewListenView Earnings Details
10/30/2014Q314$0.02($0.04)$19.53 million$18.20 millionViewListenView Earnings Details
7/30/2014Q214$0.03$0.01$19.80 million$20.05 millionViewListenView Earnings Details
4/28/2014Q114$0.01$0.04$19.44 million$20.20 millionViewListenView Earnings Details
2/26/2014Q413$0.02$0.02$18.98 million$18.90 millionViewListenView Earnings Details
10/30/2013Q313$0.02$0.04$17.35 million$17.10 millionViewListenView Earnings Details
7/31/2013Q2 2013$0.04$0.05$17.40 million$18.20 millionViewListenView Earnings Details
5/1/2013Q1 2013$0.04$0.08$17.27 million$18.00 millionViewListenView Earnings Details
2/27/2013Q4 2012$0.03$0.01$17.55 million$16.50 millionViewListenView Earnings Details
10/31/2012Q312$0.01$0.04$16.78 million$15.90 millionViewN/AView Earnings Details
8/1/2012$0.03$0.03ViewN/AView Earnings Details
5/2/2012$0.03$0.04ViewN/AView Earnings Details
3/6/2012Q4 2011$0.02$0.02ViewN/AView Earnings Details
10/24/2011Q3 2011$0.02$0.01ViewN/AView Earnings Details
8/2/2011Q2 2011$0.01$0.02ViewN/AView Earnings Details
5/3/2011Q1 2011$0.01ViewN/AView Earnings Details
3/1/2011Q4 2010$0.01($0.02)ViewN/AView Earnings Details
11/2/2010Q3 2010$0.01($0.03)ViewN/AView Earnings Details
8/3/2010Q2 2010($0.02)ViewN/AView Earnings Details
5/4/2010Q1 2010($0.01)($0.02)ViewN/AView Earnings Details
3/2/2010Q4 2009($0.03)($0.06)ViewN/AView Earnings Details
11/2/2009Q3 2009($0.03)($0.05)ViewN/AView Earnings Details
8/3/2009Q2 2009($0.01)($0.04)ViewN/AView Earnings Details
5/5/2009Q1 2009($0.05)$0.02ViewN/AView Earnings Details
3/16/2009Q4 2008($0.04)($0.12)ViewN/AView Earnings Details
10/28/2008Q3 2008($0.07)($0.08)ViewN/AView Earnings Details
7/30/2008Q2 2008($0.10)($0.09)ViewN/AView Earnings Details
5/6/2008Q1 2008($0.12)($0.30)ViewN/AView Earnings Details
3/6/2008Q4 2007($0.10)($0.15)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

STAAR Surgical (NASDAQ:STAA) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

STAAR Surgical (NASDAQ STAA) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 3.90%
Institutional Ownership Percentage: 78.92%
Insider Trading History for STAAR Surgical (NASDAQ:STAA)
Institutional Ownership by Quarter for STAAR Surgical (NASDAQ:STAA)

STAAR Surgical (NASDAQ STAA) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/3/2018Deborah J AndrewsCFOSell13,331$17.60$234,625.6028,998View SEC Filing  
3/22/2018Deborah J AndrewsCFOSell333$16.05$5,344.6515,667View SEC Filing  
3/22/2018Keith HollidayCTOSell2,188$16.03$35,073.6443,781View SEC Filing  
3/22/2018Samuel J GestenInsiderSell2,833$16.05$45,469.6538,316View SEC Filing  
3/20/2018Keith HollidayInsiderSell1,458$16.05$23,400.9045,969View SEC Filing  
3/19/2018Caren L MasonCEOSell6,667$16.09$107,272.0351,513View SEC Filing  
11/21/2017Keith HollidayVPSell6,000$16.65$99,900.0045,969View SEC Filing  
12/9/2016Hans-Martin BlickensdoerferVPSell25,000$11.14$278,500.00137,380View SEC Filing  
6/29/2016Broadwood Partners LpMajor ShareholderBuy14,144$5.24$74,114.56View SEC Filing  
5/25/2016Broadwood Partners LpMajor ShareholderBuy77,842$5.16$401,664.72View SEC Filing  
5/24/2016Broadwood Partners LpMajor ShareholderBuy70,000$5.16$361,200.00View SEC Filing  
5/23/2016Broadwood Partners LpMajor ShareholderBuy3,138$5.24$16,443.12View SEC Filing  
5/20/2016Richard A MeierDirectorSell25,000$5.35$133,750.0027,149View SEC Filing  
5/17/2016Broadwood Partners LpMajor ShareholderBuy9,313$5.23$48,706.99View SEC Filing  
5/16/2016Broadwood Partners LpMajor ShareholderBuy336,210$5.49$1,845,792.90View SEC Filing  
2/9/2016Broadwood Partners LpMajor ShareholderBuy91,770$6.25$573,562.50View SEC Filing  
2/3/2016Broadwood Partners LpMajor ShareholderBuy121,599$6.40$778,233.60View SEC Filing  
2/1/2016Broadwood Partners LpMajor ShareholderBuy65,983$6.48$427,569.84View SEC Filing  
1/27/2016Broadwood Partners LpMajor ShareholderBuy239,013$6.63$1,584,656.19View SEC Filing  
1/26/2016Broadwood Partners LpMajor ShareholderBuy112,900$6.60$745,140.00View SEC Filing  
1/25/2016Broadwood Partners LpMajor ShareholderBuy81,752$6.74$551,008.48View SEC Filing  
1/20/2016Broadwood Partners LpMajor ShareholderBuy72,858$6.75$491,791.50View SEC Filing  
1/15/2016Broadwood Partners LpMajor ShareholderBuy135,725$6.73$913,429.25View SEC Filing  
1/11/2016Broadwood Partners LpMajor ShareholderBuy86,586$6.83$591,382.38View SEC Filing  
1/7/2016Broadwood Partners LpMajor ShareholderBuy267,047$6.95$1,855,976.65View SEC Filing  
1/4/2016Broadwood Partners LpMajor ShareholderBuy165,461$7.11$1,176,427.71View SEC Filing  
9/29/2015Broadwood Partners LpMajor ShareholderBuy311,099$7.08$2,202,580.92View SEC Filing  
8/25/2015Broadwood Partners LpMajor ShareholderBuy188,881$7.17$1,354,276.77View SEC Filing  
8/24/2015Caren L MasonCEOBuy10,000$7.34$73,400.0014,500View SEC Filing  
4/6/2015Samuel J GestenVPSell3,223$7.14$23,012.22View SEC Filing  
3/3/2015Robin HughesVPSell23,253$15.82$367,862.46View SEC Filing  
11/19/2014Broadwood Partners LpMajor ShareholderBuy189,646$8.64$1,638,541.44View SEC Filing  
11/18/2014Broadwood Partners LpMajor ShareholderBuy39,400$8.67$341,598.00View SEC Filing  
11/17/2014Broadwood Partners LpMajor ShareholderBuy118,200$8.63$1,020,066.00View SEC Filing  
11/10/2014Broadwood Partners LpMajor ShareholderBuy500$8.79$4,395.00View SEC Filing  
11/7/2014Broadwood Partners LpMajor ShareholderBuy80,000$8.92$713,600.00View SEC Filing  
11/4/2014Broadwood Partners LpMajor ShareholderBuy260,341$9.20$2,395,137.20View SEC Filing  
5/15/2014John MooreDirectorSell2,800$14.87$41,636.0076,000View SEC Filing  
3/19/2014James FranceseVPSell16,666$17.22$286,988.5221,960View SEC Filing  
3/17/2014Robin HughesVPSell5,672$16.61$94,211.9256,818View SEC Filing  
9/4/2013Deborah AndrewsCFOSell50,000$12.88$644,000.0036,400View SEC Filing  
8/20/2013Deborah AndrewsCFOSell33,515$11.65$390,449.7536,400View SEC Filing  
8/12/2013Deborah AndrewsCFOSell9,079$11.62$105,497.9822,621View SEC Filing  
8/7/2013Deborah AndrewsCFOSell11,721$11.79$138,190.5924,639View SEC Filing  
5/9/2013Deborah J AndrewsCFOSell5,000$8.96$44,800.00View SEC Filing  
12/11/2012John C MooreDirectorBuy5,000$5.46$27,300.00View SEC Filing  
11/15/2012Broadwood Partners LpMajor ShareholderBuy2,618$5.00$13,090.00View SEC Filing  
11/15/2012Mark B LoganDirectorBuy3,600$5.22$18,792.00View SEC Filing  
11/14/2012Barry G CaldwellCEOBuy5,000$5.04$25,200.00View SEC Filing  
11/2/2012Broadwood Partners LpMajor ShareholderBuy22,572$5.00$112,860.00View SEC Filing  
8/9/2012Barry G CaldwellCEOBuy5,000$6.57$32,850.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

STAAR Surgical (NASDAQ STAA) News Headlines

Source:
DateHeadline
STAAR Surgical (STAA) Upgraded at BidaskClubSTAAR Surgical (STAA) Upgraded at BidaskClub
www.americanbankingnews.com - May 18 at 1:19 PM
STAAR Surgical (STAA) Upgraded by TheStreet to "B-"STAAR Surgical (STAA) Upgraded by TheStreet to "B-"
www.americanbankingnews.com - May 16 at 1:49 PM
STAAR Surgical (STAA) Upgraded by ValuEngine to "Buy"STAAR Surgical (STAA) Upgraded by ValuEngine to "Buy"
www.americanbankingnews.com - May 12 at 10:38 AM
STAAR Surgical (STAA) CFO Sells $234,625.60 in StockSTAAR Surgical (STAA) CFO Sells $234,625.60 in Stock
www.americanbankingnews.com - May 7 at 4:34 PM
STAAR Surgical (STAA) vs. The Cooper Companies (COO) Head-To-Head ContrastSTAAR Surgical (STAA) vs. The Cooper Companies (COO) Head-To-Head Contrast
www.americanbankingnews.com - May 4 at 3:29 PM
STAAR Surgical (STAA) Given New $23.00 Price Target at Canaccord GenuitySTAAR Surgical (STAA) Given New $23.00 Price Target at Canaccord Genuity
www.americanbankingnews.com - May 4 at 12:17 AM
STAAR Surgical (STAA) Lifted to Overweight at StephensSTAAR Surgical (STAA) Lifted to Overweight at Stephens
www.americanbankingnews.com - May 3 at 4:31 PM
STAAR Surgical shoots 21% post Q1 resultsSTAAR Surgical shoots 21% post Q1 results
seekingalpha.com - May 3 at 3:37 PM
Mid-Day Market Update: Dow Down Over 250 Points; STAAR Surgical Shares Spike HigherMid-Day Market Update: Dow Down Over 250 Points; STAAR Surgical Shares Spike Higher
feeds.benzinga.com - May 3 at 1:38 PM
Why Shares of STAAR Surgical Company Are Soaring TodayWhy Shares of STAAR Surgical Company Are Soaring Today
www.fool.com - May 3 at 1:21 PM
BRIEF-STAAR Surgical Reports Q1 EPS Of $0.01BRIEF-STAAR Surgical Reports Q1 EPS Of $0.01
www.reuters.com - May 3 at 10:23 AM
STAAR Surgical Co. (STAA) Has Broken Out To A New High On Q1 ResultsSTAAR Surgical Co. (STAA) Has Broken Out To A New High On Q1 Results
www.nasdaq.com - May 3 at 10:23 AM
STAAR Surgicals (STAA) CEO Caren Mason on Q1 2018 Results - Earnings Call TranscriptSTAAR Surgical's (STAA) CEO Caren Mason on Q1 2018 Results - Earnings Call Transcript
seekingalpha.com - May 3 at 10:23 AM
Staar Surgical: 1Q Earnings SnapshotStaar Surgical: 1Q Earnings Snapshot
finance.yahoo.com - May 3 at 10:23 AM
STAAR Surgical Reports First Quarter 2018 Results; Revenue Increases 33 Percent on Accelerating EVO Visian ™ ICL MomentumSTAAR Surgical Reports First Quarter 2018 Results; Revenue Increases 33 Percent on Accelerating EVO Visian ™ ICL Momentum
finance.yahoo.com - May 3 at 10:23 AM
Edited Transcript of STAA earnings conference call or presentation 2-May-18 8:30pm GMTEdited Transcript of STAA earnings conference call or presentation 2-May-18 8:30pm GMT
finance.yahoo.com - May 3 at 10:23 AM
STAAR Surgical (STAA) Posts  Earnings Results, Beats Expectations By $0.02 EPSSTAAR Surgical (STAA) Posts Earnings Results, Beats Expectations By $0.02 EPS
www.americanbankingnews.com - May 2 at 10:02 PM
Financial Analysis: STAAR Surgical (STAA) & The Cooper Companies (COO)Financial Analysis: STAAR Surgical (STAA) & The Cooper Companies (COO)
www.americanbankingnews.com - May 2 at 3:20 AM
STAAR Surgical (STAA) Given Consensus Recommendation of "Hold" by BrokeragesSTAAR Surgical (STAA) Given Consensus Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - April 30 at 11:37 AM
STAAR Surgical (STAA) Upgraded to Outperform at William BlairSTAAR Surgical (STAA) Upgraded to Outperform at William Blair
www.americanbankingnews.com - April 30 at 9:54 AM
STAAR Surgical (STAA) to Release Quarterly Earnings on WednesdaySTAAR Surgical (STAA) to Release Quarterly Earnings on Wednesday
www.americanbankingnews.com - April 25 at 5:47 AM
STAAR Surgical (STAA) Rating Reiterated by Canaccord GenuitySTAAR Surgical (STAA) Rating Reiterated by Canaccord Genuity
www.americanbankingnews.com - April 24 at 9:06 PM
Matthew Haverland Slated To Helm Staar Surgical CompanyMatthew Haverland Slated To Helm Staar Surgical Company
www.prnewswire.com - April 20 at 10:57 AM
STAAR Surgical to Report First Quarter Results on May 2, 2018STAAR Surgical to Report First Quarter Results on May 2, 2018
finance.yahoo.com - April 18 at 10:39 AM
Zacks: STAAR Surgical (STAA) Receives Consensus Rating of "Buy" from AnalystsZacks: STAAR Surgical (STAA) Receives Consensus Rating of "Buy" from Analysts
www.americanbankingnews.com - April 17 at 11:08 PM
STAAR Surgical (STAA) Cut to Sell at BidaskClubSTAAR Surgical (STAA) Cut to Sell at BidaskClub
www.americanbankingnews.com - April 17 at 9:57 AM
STAAR Surgical (STAA) and The Cooper Companies (COO) Head to Head AnalysisSTAAR Surgical (STAA) and The Cooper Companies (COO) Head to Head Analysis
www.americanbankingnews.com - April 15 at 1:21 AM
The Cooper Companies (COO) & STAAR Surgical (STAA) Head to Head SurveyThe Cooper Companies (COO) & STAAR Surgical (STAA) Head to Head Survey
www.americanbankingnews.com - April 15 at 1:21 AM
STAAR Surgical (STAA) Downgraded to "Sell" at Zacks Investment ResearchSTAAR Surgical (STAA) Downgraded to "Sell" at Zacks Investment Research
www.americanbankingnews.com - April 12 at 11:18 AM
STAAR Surgical (STAA) Rating Lowered to Sell at Zacks Investment ResearchSTAAR Surgical (STAA) Rating Lowered to Sell at Zacks Investment Research
www.americanbankingnews.com - April 6 at 10:45 AM
Contrasting National Vision (EYE) and STAAR Surgical (STAA)Contrasting National Vision (EYE) and STAAR Surgical (STAA)
www.americanbankingnews.com - April 4 at 9:34 PM
Zacks: STAAR Surgical (STAA) Receives Consensus Recommendation of "Buy" from BrokeragesZacks: STAAR Surgical (STAA) Receives Consensus Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - April 2 at 7:28 AM
STAAR Surgical (STAA) Downgraded to "Hold" at BidaskClubSTAAR Surgical (STAA) Downgraded to "Hold" at BidaskClub
www.americanbankingnews.com - March 29 at 9:15 AM
STAAR Surgical (STAA) Rating Increased to Buy at BidaskClubSTAAR Surgical (STAA) Rating Increased to Buy at BidaskClub
www.americanbankingnews.com - March 23 at 7:56 PM
Keith Holliday Sells 2,188 Shares of STAAR Surgical (STAA) StockKeith Holliday Sells 2,188 Shares of STAAR Surgical (STAA) Stock
www.americanbankingnews.com - March 22 at 2:40 PM
Insider Selling: STAAR Surgical (STAA) Insider Sells 2,833 Shares of StockInsider Selling: STAAR Surgical (STAA) Insider Sells 2,833 Shares of Stock
www.americanbankingnews.com - March 22 at 2:40 PM
Insider Selling: STAAR Surgical (STAA) Insider Sells 1,458 Shares of StockInsider Selling: STAAR Surgical (STAA) Insider Sells 1,458 Shares of Stock
www.americanbankingnews.com - March 21 at 7:50 PM
Insider Selling: STAAR Surgical (STAA) CEO Sells 6,667 Shares of StockInsider Selling: STAAR Surgical (STAA) CEO Sells 6,667 Shares of Stock
www.americanbankingnews.com - March 21 at 7:34 PM
Edited Transcript of STAA earnings conference call or presentation 28-Feb-18 9:30pm GMTEdited Transcript of STAA earnings conference call or presentation 28-Feb-18 9:30pm GMT
finance.yahoo.com - March 18 at 10:52 AM
BidaskClub Upgrades STAAR Surgical (STAA) to HoldBidaskClub Upgrades STAAR Surgical (STAA) to Hold
www.americanbankingnews.com - March 10 at 11:00 PM
STAAR Surgical (STAA) Position Trimmed by Millrace Asset Group Inc.STAAR Surgical (STAA) Position Trimmed by Millrace Asset Group Inc.
www.americanbankingnews.com - March 5 at 12:54 PM
BRIEF-Staar Surgical Q4 Sales $24.9 MillionBRIEF-Staar Surgical Q4 Sales $24.9 Million
www.reuters.com - March 2 at 3:35 PM
STAAR Surgical beats by $0.03, beats on revenueSTAAR Surgical beats by $0.03, beats on revenue
seekingalpha.com - March 2 at 3:35 PM
Form 8-K STAAR SURGICAL CO For: Feb 28Form 8-K STAAR SURGICAL CO For: Feb 28
www.streetinsider.com - March 2 at 3:35 PM
STAAR Surgical Reports Fourth Quarter and Full Year 2017 ResultsSTAAR Surgical Reports Fourth Quarter and Full Year 2017 Results
finance.yahoo.com - March 1 at 10:34 AM
STAAR Surgical (STAA) Issues Quarterly  Earnings ResultsSTAAR Surgical (STAA) Issues Quarterly Earnings Results
www.americanbankingnews.com - February 28 at 7:04 PM
Cortina Asset Management LLC Trims Holdings in STAAR Surgical (STAA)Cortina Asset Management LLC Trims Holdings in STAAR Surgical (STAA)
www.americanbankingnews.com - February 28 at 1:27 PM
Was STAAR Surgical Company’s (NASDAQ:STAA) Earnings Growth Better Than The Industry’s?Was STAAR Surgical Company’s (NASDAQ:STAA) Earnings Growth Better Than The Industry’s?
finance.yahoo.com - February 28 at 10:25 AM
74,178 Shares in STAAR Surgical (STAA) Acquired by Barrow Hanley Mewhinney & Strauss LLC74,178 Shares in STAAR Surgical (STAA) Acquired by Barrow Hanley Mewhinney & Strauss LLC
www.americanbankingnews.com - February 24 at 11:52 AM
STAAR Surgical (STAA) Scheduled to Post Quarterly Earnings on WednesdaySTAAR Surgical (STAA) Scheduled to Post Quarterly Earnings on Wednesday
www.americanbankingnews.com - February 21 at 2:40 AM

SEC Filings

STAAR Surgical (NASDAQ:STAA) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

STAAR Surgical (NASDAQ:STAA) Income Statement, Balance Sheet and Cash Flow Statement

Chart

STAAR Surgical (NASDAQ STAA) Stock Chart for Monday, May, 21, 2018

Loading chart…

This page was last updated on 5/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.